Powered by

Powered by Portfolio Grader
  • CNCR Stock Chart

  • Historical CNCR Prices

Loncar Cancer Immunotherapy ETF (CNCR) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Loncar Cancer Immunotherapy ETF Stock Analysis

Rating:

Total Grade:

Analysis Breakdown

CNCR Stock Grade:
Fundamental Grade:
Quantitative Grade:
CNCR Earnings
Earnings Growth:
Earnings Momentum:
Earnings Surprises:
Analyst Earnings Revisions:
CNCR Financial Information
Sales Growth:
Operating Margin Growth:
Cash Flow:
Return on Equity:

Loncar Cancer Immunotherapy ETF Stock: Weekly View

This Week:
Last Week:
Two Weeks Ago:
Get Full Report